|Bid||29.500 x 5000|
|Ask||30.360 x 10000|
|Day's range||30.680 - 31.265|
|52-week range||24.200 - 33.745|
|PE ratio (TTM)||19.13|
|Earnings date||27 Jul 2017|
|Dividend & yield||N/A (N/A)|
|1y target est||34.87|
Greek stocks rose for a 12th straight day on Wednesday, the longest run of gains since 1991, outperforming broadly flat European markets as Athens looked set to clinch vital bailout loans. While the pan-European ...
European shares fell on Wednesday, slipping from 21-month highs, with Italian banks and construction stocks particularly weak. The pan-European STOXX 600 index was down 0.1 percent, slipping from a high reached in the previous session and the euro zone benchmark fell 0.2 percent as German and French bluechip indexes eased from record highs. Construction and materials stocks were the biggest fallers, led by HeidelbergCement which reported its first-quarter operating profit slipped 3 percent.
Johnson & Johnson, Novartis AG and Takeda Pharmaceutical Co Ltd have expressed interest in a buyout of the controlling stake that two families have in Brazilian drugmaker Hypermarcas SA , two people with knowledge of the matter said on Monday. The owners of investment vehicles Igarapava Participações SA and Maiorem SA de CV, which hold a combined 34 percent of Hypermarcas, hired Banco Bradesco SA and Credit Suisse Group AG to advise them on options for their stakes, including a sale, said the people.